A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
Linnea ThorlaciusJohn R IngramB VillumsenS EsmannJ S KirbyA B GottliebJ F MerolaR DellavalleS M NielsenR ChristensenAmit GargGregor Borut Ernst Jemecnull nullPublished in: The British journal of dermatology (2018)
Routine adoption of the COS in future HS trials should ensure that core outcomes of importance to both patients and HCPs are collected.